These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2999782)

  • 21. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus.
    Beck TW; Huleihel M; Gunnell M; Bonner TI; Rapp UR
    Nucleic Acids Res; 1987 Jan; 15(2):595-609. PubMed ID: 3029685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of v-mos encoded proteins in cells transformed by several related murine sarcoma viruses.
    Papkoff J; Lai MH; Hunter T
    J Cell Biochem; 1982; 19(4):349-62. PubMed ID: 6298255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. v-mos protein produced by in vitro translation has protein kinase activity.
    Herzog NK; Nash M; Ramagli LS; Arlinghaus RB
    J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.
    Gojobori T; Yokoyama S
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.
    Stocking C; Kollek R; Bergholz U; Ostertag W
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5746-50. PubMed ID: 2994046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.
    van der Hoorn FA; Müller V
    Mol Cell Biol; 1985 Sep; 5(9):2204-11. PubMed ID: 3016522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ts110 Moloney mouse sarcoma virus system: gag-mos gene products and cellular transformation.
    Arlinghaus RB
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1845-53. PubMed ID: 2993477
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P55 protein affected by v-mos expression is vimentin.
    Singh B; Goldman R; Hutton L; Herzog NK; Arlinghaus RB
    J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity.
    Weinmaster G; Zoller MJ; Pawson T
    EMBO J; 1986 Jan; 5(1):69-76. PubMed ID: 3007119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the 78A1 isolate of Moloney murine sarcoma virus. I. Molecular cloning and characterization.
    Devaux J; Jouanneau J; Quibriac M; Longuet M; Le Bousse-Kerdiles MC; Auger-Buendia MA; Tavitian A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2407-14. PubMed ID: 2997374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern.
    Fusco A; Portella G; Di Fiore PP; Berlingieri MT; Di Lauro R; Schneider AB; Vecchio G
    J Virol; 1985 Oct; 56(1):284-92. PubMed ID: 2993656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase.
    Barker WC; Dayhoff MO
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2836-9. PubMed ID: 6283546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of reactive oxygen intermediates in the mutagenicity of tumor promoters.
    Biggart NW; Murphy EC
    Basic Life Sci; 1988; 49():457-60. PubMed ID: 2854992
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites.
    Kamps MP; Taylor SS; Sefton BM
    Nature; 1984 Aug 16-22; 310(5978):589-92. PubMed ID: 6431300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P85gag-mos encoded by ts110 Moloney murine sarcoma virus: rapid at the restrictive temperature.
    Stanker LH; Gallick GE; Horn JP; Arlinghaus RB
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2203-11. PubMed ID: 6311952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologically active mutants with deletions in the v-mos oncogene assayed with retroviral vectors.
    Bold RJ; Donoghue DJ
    Mol Cell Biol; 1985 Nov; 5(11):3131-8. PubMed ID: 3018503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.